Overview

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Status:
Completed
Trial end date:
2018-11-22
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label, single-arm PK study in patients for whom paclitaxel treatment is indicated.
Phase:
Phase 1
Details
Lead Sponsor:
Athenex, Inc.
Kinex Pharmaceuticals Inc
Collaborator:
PharmaEssentia
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel